Heron Therapeutics, Inc. /De/ Income Statement

Income Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Revenue & cost
Revenue 1.26M1.30M0.65M-0.60M-0.83M-0.89M-0.96M1.28M30.77M77.47M145.97M88.64M86.35M107.67M127.04M144.28M
Cost of Revenue 17.35M47.67M56.60M64.60M89.76M63.85M87.18M82.51M67.64M47.09M
Gross Profit 1.26M1.30M0.65M-0.60M-0.83M-0.89M-0.96M-46.39M-25.83M12.87M56.20M24.79M-0.83M52.80M61.94M105.64M
Operating items
Research & Development 7.80M7.26M8.21M15.17M32.52M54.83M61.18M103.12M138.58M140.03M167.38M174.53M130.82M82.70M39.13M16.68M
Selling, General & Administrative 3.71M3.97M3.50M8.66M21.94M19.73M18.39M21.37M25.55M29.26M37.90M42.23M40.15M62.24M65.78M53.40M
Other Operating Expenses 17.35M47.70M61.19M92.12M151.38M100.04M133.20M82.51M67.64M47.09M
Operating Expenses 11.50M11.23M11.71M23.83M54.46M74.56M96.92M172.19M225.32M261.41M356.66M316.80M304.17M227.46M172.55M117.17M
Operating Income -10.24M-9.93M-11.06M-23.83M-54.46M-74.56M-96.92M-170.91M-194.56M-183.94M-210.69M-228.16M-217.83M-174.66M-110.61M-11.53M
EBIT -10.24M-9.93M-11.06M-23.83M-54.46M-74.56M-96.92M-170.91M-194.56M-183.94M-210.69M-228.16M-217.83M-174.66M-110.61M-11.53M
Non-operating items
Interest & Investment Income 0.03M-0.00M-0.37M-0.60M-0.83M0.17M0.45M1.05M5.96M7.26M3.63M0.43M1.64M3.36M3.55M
Other Non Operating Income 0.24M0.01M0.00M-0.92M0.12M-0.01M-0.04M1.80M0.16M-0.85M-0.88M-6.53M0.56M0.43M
Non Operating Income 0.24M-0.60M-0.83M-1.81M-0.67M-2.23M-2.93M5.10M5.95M0.89M-2.85M-7.37M0.56M-2.05M
Net income details
EBT -10.22M-7.20M-11.44M-25.04M-56.11M-75.45M-97.71M-173.13M-197.45M-180.64M-204.91M-226.43M-219.81M-175.49M-111.12M-14.01M
Tax Provisions -0.12M
Profit After Tax -10.10M-7.35M-11.81M-24.43M-55.28M-76.37M-97.59M-173.14M-197.48M-178.84M-204.75M-227.28M-220.68M-182.02M-110.56M-13.58M
Income from Continuing Operations -10.10M-7.20M-11.44M-25.04M-56.11M-75.45M-97.71M-173.13M-197.45M-180.64M-204.91M-226.43M-219.81M-175.49M-111.12M-14.01M
Consolidated Net Income 0.07M-0.15M-0.38M1.08M-56.11M-75.45M-97.71M-173.13M-197.45M-180.64M-204.91M-226.43M-219.81M-175.49M-111.12M-14.01M
Income towards Parent Company 0.07M-0.15M-0.38M1.08M-56.11M-75.45M-97.71M-173.13M-197.45M-180.64M-204.91M-226.43M-219.81M-175.49M-111.12M-14.01M
Net Income towards Common Stockholders 0.07M-0.15M-0.38M1.08M-56.11M-75.45M-97.71M-173.13M-197.45M-180.64M-204.91M-226.43M-219.81M-175.49M-111.12M-14.01M
Additional items
EPS (Basic) -0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M-0.00M
EPS (Weighted Average and Diluted) -0.00M-0.00M-0.00M-0.00M
Shares Outstanding (Weighted Average) 1.97M2.01M10.00M15.11M15.68M29.18M35.97M39.19M54.50M78.02M90.05M90.86M101.94M118.89M150.07M152.09M
Shares Outstanding (Diluted Average) 0.10M108.88M138.13M152.45M
EBITDA -10.24M-9.93M-11.06M-23.83M-54.46M-74.56M-97.63M-173.12M-197.48M-178.92M-204.58M-227.11M-220.95M-182.04M-110.53M-13.58M
Tax Rate 1.19%